Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children : recommendations of the Advisory Committee on Immunization Practices (ACIP)

Bresee, Joseph S.; Glass, Roger I.; Vitek, Charles R.

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Superseded

This Document Has Been Replaced By: Prevention of rotavirus gastroenteritis among infants and children : recommendations of the Advisory Committee on Immunization Practices (ACIP)

Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children : recommendations of the Advisory Committee on Immunization Practices (ACIP)

March 19, 1999
By Bresee, Joseph S. ; Glass, Roger I. ; Vitek, Charles R.
Source: MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1999; 48(RR-2):1-20.
Series: MMWR. Morbidity and mortality weekly report. Recommendations and reports ; v. 48, RR-2

[PDF-432.05 KB]

English

Details You May Also Like

Details:

Alternative Title:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control
Personal Author:

Bresee, Joseph S. ; Glass, Roger I. ; Vitek, Charles R.

Bresee, Joseph S. ; Glass, Roger I. ; Vitek, Charles R. Less -
Corporate Authors:

United States. Advisory Committee on Immunization Practices. ; National Center for Infectious Diseases (U.S.). Division of Viral and Rickettsial Diseases. ; National Immunization Program (Centers for Disease Control and Prevention). Epidemiology and Surveillance Division.

United States. Advisory Committee on Immunization Practices. ; National Center for Infectious Diseases (U.S.). Division of Viral and Rickettsial Diseases. ; National Immunization Program (Centers for Disease Control and Prevention). Epidemiology and Surveillance Division. Less -
Description:

These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of an oral, live rotavirus vaccine licensed by the Food and Drug Administration on August 31, 1998, for use among infants. This report reviews the epidemiology of rotavirus, describes the licensed rotavirus vaccine, and makes recommendations regarding its use for the routine immunization of infants in the United States. These recommendations are based on estimates of the disease burden of rotavirus gastroenteritis among children in the United States and on the results of clinical trials of the vaccine. Rotavirus affects virtually all children during the first 5 years of life in both developed and developing countries, and rotavirus infection is the most common cause of severe gastroenteritis in the United States and worldwide. In the United States, rotavirus is a common cause of hospitalizations, emergency room visits, and outpatient clinic visits, and it is responsible for considerable health-care costs. Because of this large burden of disease, several rotavirus vaccines have been developed. One of these vaccines - an oral, live, tetravalent, rhesus-based rotavirus vaccine (RRV-TV) -- was found to be safe and efficacious in clinical trials among children in North America, South America, and Europe and on the basis of these studies is now licensed for use among infants in the United States. The vaccine is an oral, live preparation that should be administered to infants between the ages of 6 weeks and 1 year. The recommended schedule is a three-dose series, with doses to be administered at ages 2, 4, and 6 months. The first dose may be administered from the ages of 6 weeks to 6 months; subsequent doses should be administered with a minimum interval of 3 weeks between any two doses. The first dose should not be administered to children aged > or =7 months because of an increased rate of febrile reactions after the first dose among older infants. Second and third doses should be administered before the first birthday. Implementation of these recommendations in the United States should prevent most physician visits for rotavirus gastroenteritis and at least two-thirds of hospitalizations and deaths related to rotavirus.
Subjects:

[+]

Diarrhea, Infantile Gastroenteritis Humans Immunization Schedule Infant Rotavirus Rotavirus Infections Rotavirus Vaccines Vaccination Vaccines, Attenuated Viral Vaccines
Source:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1999; 48(RR-2):1-20.
Series:

MMWR. Morbidity and mortality weekly report. Recommendations and reports ; v. 48, RR-2
Pubmed ID:

10219046
Document Type:

Journal Issue
Volume:

48
Collection(s):

Advisory Committee on Immunization Practices (ACIP) Stephen B. Thacker CDC Library collection Morbidity and Mortality Weekly Report (MMWR) Guidelines and Recommendations
Main Document Checksum:

[+]

urn:sha256:8954596a95fcb29b8d47ce9045ac8e866885e1752c6e1c094f76c171554442c8
Download URL:

https://stacks.cdc.gov/view/cdc/7387/cdc_7387_DS1.pdf
File Type:

No Additional Files

More +

Superseded

Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children : recommendations of the Advisory Committee on Immunization Practices (ACIP)

Details:

Supporting Files

You May Also Like